These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20307577)

  • 1. Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity.
    Massé N; Davidson A; Ferron F; Alvarez K; Jacobs M; Romette JL; Canard B; Guillemot JC
    Antiviral Res; 2010 Jun; 86(3):296-305. PubMed ID: 20307577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.
    Ng CY; Gu F; Phong WY; Chen YL; Lim SP; Davidson A; Vasudevan SG
    Antiviral Res; 2007 Dec; 76(3):222-31. PubMed ID: 17662475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dengue type 2 reporter virus assay amenable to high-throughput screening.
    Li LH; Kaptein SJF; Schmid MA; Zmurko J; Leyssen P; Neyts J; Dallmeier K
    Antiviral Res; 2020 Nov; 183():104929. PubMed ID: 32898584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
    Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
    Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.
    Kato F; Hishiki T
    Viruses; 2016 May; 8(5):. PubMed ID: 27164125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
    Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
    Qing M; Liu W; Yuan Z; Gu F; Shi PY
    Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a rapid antiviral screening assay based on eGFP reporter virus of Mayaro virus.
    Li X; Zhang H; Zhang Y; Li J; Wang Z; Deng C; Jardim ACG; Terzian ACB; Nogueira ML; Zhang B
    Antiviral Res; 2019 Aug; 168():82-90. PubMed ID: 31150677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
    Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
    J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus.
    Lu CY; Hour MJ; Wang CY; Huang SH; Mu WX; Chang YC; Lin CW
    Viruses; 2017 Apr; 9(4):. PubMed ID: 28394283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.
    Kato F; Kobayashi T; Tajima S; Takasaki T; Miura T; Igarashi T; Hishiki T
    Jpn J Infect Dis; 2014; 67(3):209-12. PubMed ID: 24858611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G; Xu HY; Qing M; Wang QY; Shi PY
    Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
    Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
    Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an Arylnaphthalene Lignan Derivative as an Inhibitor against Dengue Virus Serotypes 1 to 4 (DENV-1 to -4) Using a Newly Developed DENV-3 Infectious Clone and Replicon.
    Hu M; Li WF; Wu T; Yang Y; Chen G; Chen T; Liu Y; Mei Y; Wu D; Wei Y; Luo T; Zhang HJ; Li YP
    Microbiol Spectr; 2023 Aug; 11(4):e0042323. PubMed ID: 37378517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
    Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
    Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and Application of Flavivirus Replicons.
    Kümmerer BM
    Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a stable cell line coexpressing dengue virus-2 and green fluorescent protein for screening of antiviral compounds.
    Leardkamolkarn V; Sirigulpanit W
    J Biomol Screen; 2012 Mar; 17(3):283-92. PubMed ID: 22068705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico designing and screening of lead compounds to NS5-methyltransferase of dengue viruses.
    Sivakumar D; Sivaraman T
    Med Chem; 2011 Nov; 7(6):655-62. PubMed ID: 22313305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
    Barral K; Sallamand C; Petzold C; Coutard B; Collet A; Thillier Y; Zimmermann J; Vasseur JJ; Canard B; Rohayem J; Debart F; Decroly E
    Antiviral Res; 2013 Sep; 99(3):292-300. PubMed ID: 23769894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Versatile Reporter System To Monitor Virus-Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    Pahmeier F; Neufeldt CJ; Cerikan B; Prasad V; Pape C; Laketa V; Ruggieri A; Bartenschlager R; Cortese M
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33257477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.